Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?
Restricted accessOtherFirst published online October, 2017
Proceedings of the University of Pennsylvania ninth annual conference on statistical issues in clinical trials: Where are we with adaptive clinical trial designs?
ArmitagePMcPhersonCKRoweBC. Repeated significance tests on accumulating data. J R Stat Soc Ser A1969; 132: 235–244.
2.
PocockSJ. Group sequential methods in the design and analysis of clinical trials. Biometrika1977; 64: 191–199.
3.
O’BrienPCFlemingTR. A multiple testing procedure for clinical trials. Biometrics1979; 35: 549–556.
4.
RosenbergerWFLachinJM. The use of response-adaptive designs in clinical trials. Control Clin Trials1993; 14: 471–484.
5.
BauerPKöhneK. Evaluation of experiments with adaptive interim analyses. Biometrics1994; 50: 1029–1041.
6.
FisherLD. Self-designing clinical trials. Stat Med1998; 17: 1551–1562.
7.
FreidlinBSimonR. Adaptive signature design: an adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients. Clin Cancer Res2005; 11: 7872–7878.
8.
SimonRMaitournamA. Evaluating the efficiency of targeted designs for randomized clinical trials. Clin Cancer Res2004; 10: 6759–6763.
9.
ZhouXLiuSKimESet al. Bayesian adaptive design for targeted therapy development in lung cancer—a step toward personalized medicine. Clin Trials2008; 5: 181–193.
10.
Food and Drug Administration. Guidance for industry: adaptive design clinical trials for drugs and biologics. Washington, DC: Food and Drug Administration, 2010.
11.
EllenbergJHMickREllenbergSS. Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: early, translational and proof of concept studies: the “go/no go” decisions. Stat Med2010; 29: 1059–1060.
12.
EllenbergJHEllenbergSS. Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in developing targeted therapies. Clin Trials2010; 7: 513–515.
13.
EllenbergJHEllenbergSS. Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: statistical issues in comparative effectiveness research. Clin Trials2012; 9: 5.
14.
EllenbergJHEllenbergSS. Proceedings of the University of Pennsylvania annual conference on statistical issues in clinical trials: emerging statistical issues in the conduct and monitoring of clinical trials. Clin Trials2012; 9: 669–670.
15.
EllenbergJHEllenbergSS. Proceedings of the University of Pennsylvania 5th annual conference on statistical issues in clinical trials: emerging statistical issues in biomarker validation for clinical trials. Clin Trials2013; 10: 645–646.
16.
EllenbergJHEllenbergSS. Proceedings of the University of Pennsylvania 6th annual conference on statistical issues in clinical trials: dynamic treatment regimes. Clin Trials2014; 11: 391–392.
17.
EllenbergSSEllenbergJH. Proceedings of the University of Pennsylvania 7th annual conference on statistical issues in clinical trials: the use of biomarkers and surrogate endpoints in clinical trials. Clin Trials2015; 12: 297–298.
18.
EllenbergSSEllenbergJH. Proceedings of the University of Pennsylvania eighth annual conference on statistical issues in clinical trials: statistical issues in pragmatic clinical trials. Clin Trials2016; 13: 469–470.